VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC

Blocking a key growth signal may restore immunotherapy effectiveness in hard-to-treat liver metastases.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.